Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophilic vasculitis: time for recognition of a new entity?
Arjun Datt Law1, Subhash Varma1, Neelam Varma2
1Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160 012 India.
Hypereosinophilic syndrome can cause severe blood clots and vasculitis. Prompt treatment with corticosteroids effectively resolved symptoms in a young male patient.
Area of Science:
- Hematology
- Rheumatology
- Vascular Medicine
Background:
- Hypereosinophilia is a complex condition involving multiple organ systems.
- It can manifest with serious vascular complications, including arterial and venous thrombosis.
Observation:
- A 23-year-old male presented with extensive thrombosis and impending gangrene.
- He exhibited marked peripheral blood eosinophilia (27,669/μL) and eosinophilic infiltration in skin biopsies showing vasculitis.
Findings:
- Bone marrow examination ruled out clonal disorders.
- Extensive investigations excluded secondary causes of hypereosinophilia.
- The patient's vascular events and cutaneous vasculitis were attributed to hypereosinophilic syndrome.
Implications:
- This case highlights the link between hypereosinophilic syndrome, vasculitis, and thrombosis.
- High-dose corticosteroids proved effective in managing this rare condition.
- Further research into eosinophilic vasculitis and its thrombotic associations is warranted.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Esophageal Achalasia
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
Asthma I: Introduction

